There have recently been safety concerns regarding an increased risk of vaccine-induced immune thrombotic thrombocytopenia (VITT) following administration of SARS-CoV-2 adenoviral vector vaccines. The Southern African Society of Thrombosis and Haemostasis reviewed the emerging literature on this idiosyncratic complication. A draft document was produced and revised by consensus agreement by a panel of professionals from various specialties. The recommendations were adjudicated by independent international experts to avoid local bias. We present concise, practical guidelines for the clinical management of VITT.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
vaccine-induced immune
8
immune thrombotic
8
thrombotic thrombocytopenia
8
recommendations diagnosis
4
diagnosis management
4
management vaccine-induced
4
thrombocytopenia safety
4
safety concerns
4
concerns increased
4
increased risk
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!